Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rusert

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Plos Pathogens|May 5, 2017
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parametersOliver F Brandenberg, Carsten Magnus, Peter Rusert, et al.
Plos Pathogens|April 13, 2012
Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodiesIrene A Abela, Livia Berlinger, Merle Schanz, et al.
EMBO Molecular Medicine|June 10, 2010
HIV-1 replication activates CD4+ T cells with specificities for persistent herpes virusesAnna Haas, Manuela Rehr, Frederik Graw, et al.
Virology|July 21, 2004
Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocolPeter Rusert, Marek Fischer, Beda Joos, et al.
Retrovirology|October 8, 2014
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variationOliver F Brandenberg, Peter Rusert, Carsten Magnus, et al.
Journal of Virology|November 23, 2007
In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titersAlexandra Trkola, Herbert Kuster, Peter Rusert, et al.
The Journal of Experimental Medicine|June 8, 2011
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodiesPeter Rusert, Anders Krarup, Carsten Magnus, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 16, 2009
Association between specific HIV-1 Env traits and virologic control in vivoBeda Joos, Philip Rieder, Marek Fischer, et al.
Journal of Virology|June 15, 2007
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10Amapola Manrique, Peter Rusert, Beda Joos, et al.
AIDS (London, England)|March 15, 2005
Complement dependent trapping of infectious HIV in human lymphoid tissuesZoltán Bánki, Laco Kacani, Peter Rusert, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Plos Pathogens|May 5, 2017
Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parametersOliver F Brandenberg, Carsten Magnus, Peter Rusert, et al.
Plos Pathogens|April 13, 2012
Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodiesIrene A Abela, Livia Berlinger, Merle Schanz, et al.
EMBO Molecular Medicine|June 10, 2010
HIV-1 replication activates CD4+ T cells with specificities for persistent herpes virusesAnna Haas, Manuela Rehr, Frederik Graw, et al.
Virology|July 21, 2004
Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocolPeter Rusert, Marek Fischer, Beda Joos, et al.
Retrovirology|October 8, 2014
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variationOliver F Brandenberg, Peter Rusert, Carsten Magnus, et al.
Journal of Virology|November 23, 2007
In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titersAlexandra Trkola, Herbert Kuster, Peter Rusert, et al.
The Journal of Experimental Medicine|June 8, 2011
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodiesPeter Rusert, Anders Krarup, Carsten Magnus, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 16, 2009
Association between specific HIV-1 Env traits and virologic control in vivoBeda Joos, Philip Rieder, Marek Fischer, et al.
Journal of Virology|June 15, 2007
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10Amapola Manrique, Peter Rusert, Beda Joos, et al.
AIDS (London, England)|March 15, 2005
Complement dependent trapping of infectious HIV in human lymphoid tissuesZoltán Bánki, Laco Kacani, Peter Rusert, et al.
Pageof 5